American Society of Hematology

SHERPA: Blue

People

  1. Park
    Park
  2. Sadelain
    Sadelain
  3. Palomba
    Palomba
  4. Giralt
    Giralt
  5. Wang
    Wang
  6. Devlin
    Devlin
  7. Geyer
    Geyer
  8. Perales
    Perales
  9. Abdel-Wahab
    Abdel-Wahab
  10. Shah
    Shah

Groups

  1. Adult Leukemia (128)
  2. Center for Hematologic Malignancies (128)
  3. Department of Medicine (128)
  4. Hematologic Malignancies, Division of (128)
  5. GSK Faculty (73)
  6. Hematologic Malignancies Research (51)
  7. Sloan Kettering Institute Faculty (42)
  8. Molecular Pharmacology and Chemistry Program Faculty (37)
  9. Bone Marrow Transplant (36)
  10. Epidemiology and Biostatistics (36)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Jae Park"
  3. "Blood"
Formats
  1. Meeting Abstract (111)
  2. Journal Article (17)
Groups
  1. Adult Leukemia (128)
  2. Center for Hematologic Malignancies (128)
  3. Department of Medicine (128)
  4. Hematologic Malignancies, Division of (128)
  5. GSK Faculty (73)
  6. Hematologic Malignancies Research (51)

More Groups

People
  1. Jae Park (128)
  2. Martin Tallman (38)
  3. Renier Brentjens (37)
  4. Isabelle Riviere (29)
  5. Michel Sadelain (29)
  6. Maria Palomba (26)

More People

Years
  1. 2023 (18)
  2. 2022 (8)
  3. 2021 (13)
  4. 2020 (5)
  5. 2019 (15)
  6. 2018 (13)

More Years

Publications
  1. Blood (128)

Results (128)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation
    Meeting Abstract

    Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluation of the impact of tocilizumab use in recipients of CAR T cells for non-Hodgkin lymphoma
    Meeting Abstract

    Cassanello, G.; Luttwak, E.; Devlin, S. M.; Luna De Abia, A.; Corona, M.; Landego, I.; Parascondola, A.; Saldia, A.; Tomas, A. A.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Venetoclax in combination with pediatric-inspired chemotherapy in adults with newly diagnosed acute lymphoblastic leukemia: Results of a phase I trial
    Meeting Abstract

    Valtis, Y. K.; Geyer, M. B.; Torres, M.; Grogan, M.; Shukla, M.; Stein, E. M.; Park, J. H.
    Blood (2023)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Obecabtagene autoleucel (obe-cel, AUTO1) for relapsed/refractory adult B-cell acute lymphoblastic leukemia (R/R B-ALL): Pooled analysis of the ongoing FELIX phase Ib/II study
    Meeting Abstract

    Roddie, C.; Sandhu, K. S.; Tholouli, E.; Shaughnessy, P.; Barba, P.; Guerreiro, M.; Bishop, M. R.; Yared, J. A.; Ghobadi, A.; Yallop, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of obecabtagene autoleucel (obe-cel) in adult patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia ([R/R B-ALL]; Pooled analysis from ALLCAR19 and FELIX phase Ib studies) or other B-cell malignancies (ALLCAR19 extension study)
    Meeting Abstract

    Roddie, C.; Tholouli, E.; Shaughnessy, P.; Jabbour, E.; Logan, A. C.; Hodby, K.; Mountjoy, L.; Bloor, A. J. C.; Irvine, D.; Linch, D. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long-term follow up for SWOG 1318: Combination of dasatinib, prednisone, and blinatumomab for older patients with philadelphia-chromosome (Ph) positive acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Advani, A. S.; Moseley, A. B.; O'Dwyer, K. M.; Wood, B. L.; Park, J. H.; Wieduwilt, M. J.; Jeyakumar, D.; Yaghmour, G.; Atallah, E. L.; Gerds, A. T.; more...
    Blood (2023)

    Fulltext@MSK | Save